IM Cannabis Corp. current report, Q4 FY2022

IM Cannabis Corp. Form 6-K Summary

Business context and reporting period

IM Cannabis Corp., an Israeli foreign private issuer, filed Form 6-K for October 2022 with the U.S. Securities and Exchange Commission. The filing was signed on October 5, 2022, by Oren Shuster, Chief Executive Officer and Director.

The submission identifies Exhibit 99.1 as a news release dated October 5, 2022, but the news release text is not included in the provided filing content.

Financial metrics

The provided filing text does not include revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material changes versus the prior comparable period

The filing text does not provide information sufficient to assess changes from a prior comparable period.

Guidance, outlook, risks, and unusual items

The filing text does not provide guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items. These matters may have been addressed in the referenced Exhibit 99.1, which is not included.

Key facts for investor verification

  • Obtain and review Exhibit 99.1, the October 5, 2022 news release.
  • Verify whether the exhibit contains operating or financial results, corporate developments, guidance, or material risk disclosures.
  • Confirm any numerical data, transaction details, or management statements directly against the complete SEC filing and related company disclosures.